Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Many women require re-operation after TVM use

Posted in Vaginal Mesh

Transvaginal mesh (TVM) is a fairly new mesh-augmented suspension system, only becoming commercially available in 2004.  Early studies reported a promising short-term anatomical success rate of 94%.  Further studies were deemed necessary after the Food and Drug Administration reported several adverse outcomes associated with the use of these mesh kits.

One such study, titled “Two-Year Outcomes After Vaginal Prolapse Reconstruction With Mesh Pelvic Floor Repair System,” was conducted by Marianna Alperin, et at. The study was published in the journal of Female Pelvic Medicine & Reconstructive Surgery.  “The aim of this prospective observational study was to investigate anatomical and functional outcomes 2 years after prolapse repair using the Prolift mesh kits.”  Functional outcomes were evaluated with questionnaires assessing pelvic symptoms, quality of life, sexual function, and global satisfaction.  Anatomical data were collected by conducting a pelvic examination for anatomical support and mesh complications; the Pelvic Organ Quantification (POPQ) examination was used to measure uterine and vaginal support.

Study participants included 85 women, who had enrolled in a similar previous one-year study.  At the two-year follow-up subjective, or functional, outcomes were evaluated for 82 women.  While objective, or anatomical, data was collected for 79 of the participants.  Of all the procedures evaluated 55% were total prolift procedures, 29% anterior prolift, and 15% posterior prolift.  Prolapse was very common among the participants, although none suffered beyond stage III.  Sixty-five percent of the participants experienced only stage 0/I prolapse, 31% were treated for stage II prolapse, while only 4% of the participants were treated for stage III prolapse.

This particular study concluded that procedures using TVM are for the most part quite effective.  The author states “These data show that at the 2-year follow-up, the Profit system achieves anatomical support, significant symptom relief, and high patient satisfaction.  However, mesh exposure and new-onset prolapse of the non-operated compartment are not uncommon.”

Due to the fact that so many women suffer from POP and require transvaginal mesh, unpredicted problems with vaginal mesh repair kits affect millions of women around the world.  And, since many of these risks, such as the risk for vaginal mesh erosion, vaginal mesh-related infection, and other TVM complications have not been adequately explained to vaginal mesh users, transvaginal mesh lawsuits are being filed in great number today.

If you or a loved one used transvaginal mesh and experienced a harmful side effect of vaginal mesh, you may be entitled to significant financial compensation. For more information or a free, no-obligation case consultation, contact our team of transvaginal mesh lawyers at the information provided below.

(855) 452-5529

justinian@dangerousdrugs.us

Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have any questions about Transvaginal Mesh.